Skip to main content
. Author manuscript; available in PMC: 2017 Oct 24.
Published in final edited form as: Hepatoma Res. 2017 May 9;3:79–85. doi: 10.20517/2394-5079.2017.06

Table 3.

Patient characteristics significantly affecting 3-year and 5-year overall survival

Characteristic n OR of 3-year OS (95% CI) P - value OR of 5-year OS (95% CI) P - value
MELD < 10 54 4.43 (1.85, 10.58) 0.0008 2.77 (1.19, 6.46) 0.0181
APRI ≤ 0.5 31 4.25 (1.63, 11.08) 0.0031 4.09 (1.59, 10.50) 0.0034
Creatinine ≤ 1.0 55 6.28 (2.09, 18.86) 0.0010 4.15 (1.39, 12.36) 0.0107
Diabetes 22 0.22 (0.072, 0.66) 0.0070 0.32 (0.11, 0.97) 0.0438
Age > 60 41 0.42 (0.18, 0.96) 0.0396 0.32 (0.14, 0.75) 0.0089
Bilirubin ≤ 1.2 46 2.28 (0.99, 5.24) 0.0520 2.19 (0.95, 5.06) 0.0677
Albumin ≥ 3.0 67 3.50 (1.22, 10.07) 0.0201 2.36 (0.82, 6.78) 0.1093
CTP score ≤ 6 58 2.23 (0.95, 5.21) 0.0649 2.00 (0.84, 4.74) 0.1155

OR: odds ratio; OS: overall survival; CI: confidence interval